These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15201094)

  • 1. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
    Shang JB; Li YH; Liu FY; Zeng QL; Wang JY; He XF; Chen Y
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):697-9. PubMed ID: 15201094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and
    Rhee WJ; Hwang SH; Byun HK; Yun M; Han KH; Seong J
    Liver Int; 2017 Apr; 37(4):592-599. PubMed ID: 27804192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
    Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
    Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
    Song MJ; Bae SH; Yoo IeR; Park CH; Jang JW; Chun HJ; Choi BG; Lee HG; Choi JY; Yoon SK
    World J Gastroenterol; 2012 Jul; 18(25):3215-22. PubMed ID: 22783045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
    Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
    Ali SA; Amin DH; Abdelkhalek YI
    Jpn J Radiol; 2020 May; 38(5):472-479. PubMed ID: 32078123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH; Han CJ; Lee SD; Sohn WS; Kim MJ; Ki SS; Kim J; Jeong SH; Kim YC; Lee JO; Cheon GJ; Choi CW; Lim SM
    Korean J Hepatol; 2004 Dec; 10(4):279-87. PubMed ID: 15613803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
    Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
    Boussouar S; Itti E; Lin SJ; Decaens T; Evangelista E; Chiaradia M; Chalaye J; Baranes L; Calderaro J; Laurent A; Pigneur F; Duvoux C; Azoulay D; Costentin C; Rahmouni A; Luciani A
    Cancer Imaging; 2016 Feb; 16():4. PubMed ID: 26883745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
    Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
    Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients.
    Kornberg A; Küpper B; Thrum K; Katenkamp K; Steenbeck J; Sappler A; Habrecht O; Gottschild D
    Transplant Proc; 2009; 41(6):2561-3. PubMed ID: 19715974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
    Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
    J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early prediction of microvascular invasion (MVI) occurrence in hepatocellular carcinoma (HCC) by
    Wang T; Chen X; Huang H; Jia N
    Eur J Med Res; 2024 Jul; 29(1):395. PubMed ID: 39080787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.